{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T07:31:55Z","timestamp":1789975915419,"version":"4.0.1"},"reference-count":26,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T00:00:00Z","timestamp":1176854400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Since 1997, a number of trials have shown promising results in treating generalized vitiligo with narrowband ultraviolet B (UVB) both in adults and children. However, there is little knowledge concerning the duration and permanency of the treatment\u2010induced repigmentation.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> Our main objective was to perform a follow\u2010up trial of successfully treated patients receiving narrowband UVB for generalized vitiligo.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> We have investigated to what degree the treatment\u2010induced repigmentation remains stable for up to 2\u00a0years post\u2010treatment. We performed an initial open trial including 31 patients with generalized vitiligo. They received narrowband UVB thrice weekly for up to 12\u00a0months. Patients experiencing &gt;\u00a075% repigmentation were defined responders and were included in the follow\u2010up trial. Responders were followed every 6\u00a0months for up to 2\u00a0years after cessation of treatment. We observed the pigmentation status and registered any changes indicating loss of pigmentation and relapse.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Eleven of the 31 treated patients were included in the follow\u2010up trial. Six patients had relapse and five patients had stable response 24\u00a0months after cessation of treatment. Four out of six relapses were within 6\u00a0months post\u2010treatment.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> In our study population of 31 patients with generalized vitiligo, five patients (16%) experienced\u00a0&gt;\u00a075% stable repigmentation 2\u00a0years after cessation of a treatment programme of up to 1\u00a0years narrowband UVB therapy.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2007.01980.x","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T11:37:35Z","timestamp":1176896255000},"page":"891-896","source":"Crossref","is-referenced-by-count":44,"title":["Narrowband UVB therapy for vitiligo: does the repigmentation last?"],"prefix":"10.1111","volume":"21","author":[{"given":"JC","family":"Sitek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JR","family":"Ronnevig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,4,18]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-9272-3"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70119-4"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1992.tb03978.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.1993.tb00023.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1984.01650410073019"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00623.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(97)00133-8"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70255-2"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30302.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.126250"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.05.036"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.415"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1997.03890480045006"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90133-6"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114752"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01484-1"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0781.2003.00039.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.6.677"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2004.00114.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155502320624113"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2004.01.007"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/1011-1344(88)80002-2"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1080\/00015550410026948"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06537.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1001\/archderm.1995.01690180114025","article-title":"Cutaneous malignancies in patients treated with photochemotherapy (PUVA) for vitiligo","volume":"131","author":"Halder RM","year":"1995","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1159\/000057881"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2007.01980.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2007.01980.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T19:57:05Z","timestamp":1696967825000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2007.01980.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,18]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1468-3083.2007.01980.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2007.01980.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,18]]}}}